Gastric Ulcers

Gastric ulcers in dogs are localized erosions of the stomach lining that extend beyond the superficial mucosa into the deeper layers of the stomach wall. While the stomach naturally produces strong acid to aid digestion, a complex protective barrier normally prevents this acid from damaging the stomach's own tissues. When this protective barrier is compromised, acid and digestive enzymes erode the stomach wall, creating painful ulcers that can cause significant illness and potentially life-threatening complications. Gastric ulcers are a recognized complication of certain medications, diseases, and stress conditions in dogs.

The pathophysiology of gastric ulcers involves an imbalance between the protective and damaging factors affecting the stomach lining. The gastric mucosa is normally protected by a thick layer of mucus, bicarbonate secretion that neutralizes acid at the surface, robust blood flow that supports cellular repair, and rapid turnover of mucosal cells. When these protective mechanisms are impaired or overwhelmed by increased acid production or direct damage to the lining, ulceration develops. The process typically begins with superficial erosions that may progress to deeper ulcers if the underlying cause is not addressed.

The clinical significance of gastric ulcers in dogs varies widely depending on their size, depth, and underlying cause. Superficial ulcers may cause mild discomfort and respond readily to treatment, while deep ulcers can erode through blood vessels and cause life-threatening hemorrhage or perforate the stomach wall completely, leading to peritonitis. Dogs with ulcers often experience significant pain, nausea, and reduced appetite that affects their quality of life. Chronic ulcers can lead to anemia, weight loss, and debilitation. Understanding the causes and recognizing the symptoms of gastric ulcers enables prompt treatment and prevention of serious complications.

Treatment of gastric ulcers focuses on reducing stomach acid, protecting the damaged mucosa, and addressing the underlying cause. Most ulcers respond well to medical management with acid-suppressing medications and gastric protectants. However, identifying and eliminating the cause of ulceration is essential for healing and prevention of recurrence. Dogs with ulcers from NSAID use need alternative pain management strategies, while those with ulcers from underlying diseases require treatment of the primary condition. With appropriate therapy, most gastric ulcers heal within several weeks.

Gastric ulcers in dogs develop when factors that damage the stomach lining outweigh the protective mechanisms that normally maintain mucosal integrity. Understanding these causes is essential for both treatment and prevention, as eliminating the underlying cause is necessary for complete healing and prevention of recurrence. Most cases of gastric ulceration in dogs result from medications, systemic diseases, or stress-related factors.

Non-steroidal anti-inflammatory drugs represent the most common cause of gastric ulcers in dogs. NSAIDs work by inhibiting cyclooxygenase enzymes, which reduces inflammation and pain but also decreases production of prostaglandins that protect the gastric mucosa. The protective prostaglandins normally stimulate mucus and bicarbonate secretion, maintain mucosal blood flow, and support cellular repair. When these functions are impaired, the stomach lining becomes vulnerable to acid-mediated damage. All NSAIDs carry some risk of gastrointestinal ulceration, though newer COX-2 selective drugs may be somewhat safer than older non-selective NSAIDs. Risk factors that increase NSAID-induced ulceration include high doses, prolonged use, concurrent corticosteroid administration, and pre-existing gastrointestinal disease.

Corticosteroid medications, particularly when used at high doses or for extended periods, can contribute to gastric ulceration. While corticosteroids alone are considered relatively low risk for ulcer formation, their combination with NSAIDs dramatically increases the likelihood of gastrointestinal complications. Corticosteroids impair mucosal healing and may mask early symptoms of ulceration, allowing disease to progress before it is recognized. Dogs receiving concurrent NSAID and corticosteroid therapy require careful monitoring and gastroprotective medications.

Systemic diseases affecting the liver, kidneys, and other organ systems frequently cause or contribute to gastric ulceration. Liver disease is strongly associated with gastrointestinal ulceration through multiple mechanisms including altered gastrin metabolism, portal hypertension, and impaired synthesis of protective proteins. Kidney disease, particularly uremia, causes gastric mucosal damage and ulceration. Severe pancreatitis can lead to gastric ulceration through local inflammation and systemic effects. Hypoadrenocorticism (Addison's disease) may present with gastrointestinal ulceration. Mast cell tumors release histamine that stimulates excessive acid production, frequently causing severe ulceration.

Stress-related and critical illness ulcers develop in dogs experiencing severe physiological stress. Major surgery, trauma, shock, sepsis, and severe burns can all trigger stress ulceration through mechanisms including reduced mucosal blood flow, increased acid secretion, and impaired protective barrier function. Dogs with neurological disease, particularly those with increased intracranial pressure, may develop stress ulcers. Critically ill dogs in intensive care settings are at particular risk and often receive prophylactic gastroprotective medications. Extreme athletic stress in working and sporting dogs has also been associated with gastric erosions and ulcers.

The symptoms of gastric ulcers in dogs range from subtle signs of digestive discomfort to dramatic life-threatening hemorrhage or perforation. The severity of symptoms generally correlates with the depth and extent of ulceration, though some dogs with significant disease may show minimal outward signs until complications develop. Recognizing the symptoms of gastric ulceration enables prompt diagnosis and treatment before serious complications occur.

Early signs of gastric ulcers are often nonspecific and may be easily overlooked or attributed to minor digestive upset. Reduced appetite is common, with affected dogs showing less enthusiasm for meals or eating smaller amounts than usual. Intermittent nausea may manifest as drooling, lip-licking, or swallowing motions when not eating. Dogs may appear uncomfortable after eating or show reluctance to eat despite apparent hunger. Some dogs may eat grass or seek unusual items to eat in an apparent attempt to settle their stomach. These subtle signs may persist for days to weeks before more obvious symptoms develop.

Vomiting is a hallmark symptom of gastric ulcers and often has characteristics that suggest the diagnosis. The vomit may appear normal initially but often contains bile, indicating gastric irritation. As ulcers progress, blood may appear in the vomit, ranging from fresh red blood to digested blood that looks like coffee grounds. This hematemesis is a significant finding that warrants immediate veterinary attention. Some dogs vomit primarily in the early morning when the stomach is empty and acid concentration is highest. The frequency of vomiting varies from occasional episodes to persistent retching in severe cases.

Abdominal pain from gastric ulcers may be expressed in various ways. Dogs may assume a prayer position with front legs down and rear end elevated, which relieves pressure on the abdomen. Reluctance to move, exercise, or jump may indicate abdominal discomfort. Some dogs become protective of their abdomen, flinching or tensing when touched in that area. Others may vocalize or show signs of distress, particularly after eating. The severity of pain does not always correlate with ulcer severity, as some deep ulcers cause less pain than extensive superficial erosions.

Gastrointestinal bleeding from ulcers produces characteristic signs that indicate the severity of blood loss. Dark, tarry stools known as melena result from digested blood passing through the intestinal tract and indicate bleeding in the upper gastrointestinal tract. Fresh red blood in the stool is less common with gastric ulcers but can occur with rapid, severe bleeding. Pale gums indicate anemia from chronic or acute blood loss and represent a serious warning sign. Dogs with significant bleeding may become weak, lethargic, or collapse due to hypovolemia and anemia.

Emergency symptoms indicating severe complications require immediate veterinary intervention. Sudden collapse, extreme weakness, or an inability to stand suggests acute severe hemorrhage or perforation. Marked abdominal distension with pain indicates possible perforation and peritonitis. Fever combined with abdominal pain suggests perforation with contamination of the abdominal cavity. Rapid, weak pulse with pale or white gums indicates cardiovascular shock. Any suspicion of gastric perforation or severe hemorrhage constitutes a life-threatening emergency requiring immediate veterinary care.

Diagnosing gastric ulcers in dogs requires clinical suspicion based on symptoms and risk factors, followed by diagnostic testing to confirm ulceration, assess severity, and identify underlying causes. While the clinical presentation may strongly suggest gastric ulceration, definitive diagnosis typically requires visualization of the stomach lining or detection of gastrointestinal bleeding. A thorough diagnostic workup also helps guide treatment decisions and establish prognosis.

The initial veterinary assessment combines history, physical examination, and assessment of risk factors. The veterinarian will inquire about any medications the dog receives, particularly NSAIDs and corticosteroids, as well as the dog's overall health status and any known medical conditions. Physical examination may reveal abdominal pain on palpation, dehydration from vomiting, or pale mucous membranes suggesting anemia. Rectal examination may reveal black, tarry stool indicative of upper gastrointestinal bleeding. The presence of risk factors combined with compatible symptoms raises clinical suspicion for gastric ulceration.

Laboratory testing provides important information about the dog's overall status and may suggest gastrointestinal bleeding. A complete blood count often reveals anemia in dogs with significant ulcer-related blood loss, which may be regenerative if bleeding has been ongoing long enough for the bone marrow to respond. Serum chemistry panels assess liver and kidney function, which may identify underlying diseases contributing to ulceration. Coagulation testing may be performed to rule out bleeding disorders. Fecal occult blood testing can detect small amounts of blood in the stool that may not be visible, supporting the diagnosis of gastrointestinal bleeding.

Endoscopy provides the most definitive diagnosis of gastric ulcers and is considered the gold standard for evaluation. During endoscopy, a flexible camera is passed through the mouth into the stomach, allowing direct visualization of the mucosal surface. Ulcers appear as localized defects in the lining, and their depth, number, and location can be assessed. Bleeding ulcers may be identified and sometimes treated during the procedure. Biopsies can be collected to evaluate for underlying causes such as neoplasia or inflammatory conditions. Endoscopy also allows evaluation of the esophagus and upper small intestine for concurrent disease.

Additional imaging and diagnostic testing may be necessary depending on clinical findings. Abdominal radiographs can identify free gas in the abdomen if perforation has occurred, though they do not visualize ulcers themselves. Abdominal ultrasound may reveal gastric wall thickening or abnormalities but is limited for ulcer detection. Contrast studies with barium can sometimes demonstrate ulcer craters but are largely replaced by endoscopy for diagnosis. Testing for specific underlying conditions, such as adrenal function tests, mast cell tumor evaluation, or liver disease workup, may be indicated based on initial findings.

Treatment of gastric ulcers in dogs aims to reduce gastric acid production, protect the damaged mucosa, allow healing to occur, and address any underlying cause of ulceration. The approach varies based on ulcer severity, the presence of complications, and the identified or suspected cause. Most uncomplicated gastric ulcers respond well to medical management, though severe cases may require more intensive intervention including hospitalization and potentially surgery.

Acid suppression forms the cornerstone of ulcer treatment, dramatically reducing injury to the damaged mucosa and creating conditions that favor healing. Proton pump inhibitors such as omeprazole are highly effective acid suppressors and are commonly prescribed for gastric ulcers. These medications block the final step of acid secretion in the stomach lining and can reduce acid production by more than 90 percent. H2-receptor antagonists such as famotidine provide an alternative or adjunctive acid suppression, though they are generally less potent than proton pump inhibitors. Treatment typically continues for several weeks to ensure complete healing.

Mucosal protectants help shield the damaged stomach lining and promote healing. Sucralfate is the most commonly used gastroprotectant in dogs and works by forming a protective paste over ulcerated areas when it contacts stomach acid. This barrier protects the ulcer from further acid exposure and allows healing to proceed. Sucralfate is most effective when given on an empty stomach, at least one hour before other medications. Misoprostol is a synthetic prostaglandin that enhances mucosal protection and is particularly useful for preventing or treating NSAID-induced ulcers. Additional agents such as antacids and bismuth compounds may be used in some cases.

Addressing the underlying cause of ulceration is essential for complete healing and prevention of recurrence. If NSAIDs are identified as the cause, they must be discontinued immediately, and alternative pain management strategies must be implemented. This may include using different drug classes such as gabapentin or tramadol, or pursuing non-pharmacological approaches like physical therapy, weight management, or acupuncture. If corticosteroids are contributing, doses should be reduced if medically feasible. Underlying diseases such as liver disease, kidney disease, or mast cell tumors require specific treatment. Without addressing the cause, ulcers are likely to recur or fail to heal despite medical management.

Hospitalization and intensive care may be necessary for dogs with severe ulcers or complications. Dogs with significant bleeding require intravenous fluid therapy to maintain circulation and may need blood transfusions if anemia is severe. Anti-emetic medications control vomiting and reduce further trauma to the damaged stomach. Pain management is important for patient comfort. Parenteral nutrition or feeding tube placement may be necessary if oral feeding is not tolerated. Serial monitoring of packed cell volume and vital signs guides transfusion decisions and assesses response to treatment.

Surgical intervention is reserved for ulcers that fail to respond to medical management or that develop life-threatening complications. Perforated ulcers require emergency surgery to close the defect and lavage the contaminated abdomen. Uncontrolled hemorrhage from a bleeding ulcer may require surgical ligation of bleeding vessels or partial gastrectomy to remove the affected tissue. Ulcers caused by tumors may require surgical resection. The decision to pursue surgery considers the dog's overall condition, the likelihood of surgical success, and the underlying cause of ulceration.

Recovery from gastric ulcers in dogs depends on the severity of ulceration, the presence of complications, the underlying cause, and how well the dog responds to treatment. Most uncomplicated gastric ulcers heal within two to four weeks with appropriate medical management, though complete recovery may take longer. Dogs with complicated ulcers or those requiring surgery face longer recovery periods with more guarded prognoses. Understanding the recovery process helps owners provide optimal supportive care.

The initial recovery phase focuses on controlling symptoms and beginning the healing process. Vomiting typically decreases within the first few days of treatment as acid suppression takes effect. Appetite usually improves gradually over the first one to two weeks. During this period, dogs should be fed small, frequent meals of bland, easily digestible food to minimize gastric workload. Pain and discomfort should noticeably decrease as ulcers begin to heal. Medications must be given consistently as prescribed, and any medications that may have caused ulceration must remain discontinued. Veterinary rechecks assess response to treatment and allow medication adjustments if needed.

Recovery timelines vary based on ulcer severity and underlying factors. Superficial ulcers and erosions may heal within one to two weeks with appropriate treatment. Deeper ulcers typically require three to four weeks or longer for complete healing. Dogs with ulcers caused by underlying diseases may require ongoing management of the primary condition even after the ulcers heal. Treatment duration for acid suppression and gastroprotective medications is typically four to six weeks minimum, with longer courses for severe or complicated cases. Follow-up endoscopy may be recommended to confirm healing in severe cases.

Prognostic factors influencing recovery and outcome include the depth of ulceration, presence of complications, underlying cause, and response to initial treatment. Dogs with uncomplicated ulcers from NSAID use have excellent prognoses when the medication is discontinued and appropriate treatment is provided. Those with ulcers secondary to serious underlying diseases such as liver failure or widespread neoplasia have prognoses determined primarily by the underlying condition rather than the ulcers themselves. Dogs that experience perforation or require surgery have more guarded prognoses, with survival rates depending on the extent of contamination and the dog's overall condition.

Long-term outlook following recovery from gastric ulcers is generally good for dogs without serious underlying conditions. Once healed, ulcers typically do not cause ongoing problems, though the stomach may be somewhat more susceptible to future ulceration. Dogs that required NSAIDs for pain management need alternative approaches established and may benefit from gastroprotective medications if NSAIDs must be used in the future. Regular veterinary monitoring helps detect any recurrence early. Dietary management with easily digestible food and avoidance of known triggers supports ongoing gastric health.

Prevention of gastric ulcers in dogs focuses primarily on minimizing exposure to known ulcer-causing factors, using gastroprotective strategies when risk cannot be avoided, and maintaining overall health to support gastric mucosal integrity. Since drug-induced ulcers represent the most common cause in veterinary patients, thoughtful medication management is central to prevention. For dogs with underlying conditions that predispose to ulceration, proactive gastroprotection can significantly reduce risk.

Safe NSAID use represents the most important preventive strategy given that these medications cause most gastric ulcers in dogs. NSAIDs should only be used when clearly indicated and at the lowest effective dose for the shortest duration necessary. Concurrent use of corticosteroids with NSAIDs should be avoided whenever possible due to dramatically increased ulceration risk. Dogs receiving long-term NSAIDs should have regular veterinary monitoring for gastrointestinal and other side effects. Using newer, more COX-2 selective NSAIDs may provide some additional safety, though no NSAID is completely without gastrointestinal risk.

Gastroprotective medications can prevent ulceration in dogs at increased risk. Dogs requiring long-term NSAID therapy, particularly older dogs or those with previous gastrointestinal issues, benefit from concurrent acid suppression with proton pump inhibitors or H2-receptor antagonists. Misoprostol provides particularly effective protection against NSAID-induced ulcers by replacing the prostaglandins that NSAIDs deplete. Sucralfate may be added for additional mucosal protection. Dogs receiving high-dose corticosteroids, those with liver disease, and critically ill patients should receive prophylactic gastroprotection. The cost of preventive medications is far less than treating established ulcers.

Managing underlying health conditions helps prevent secondary ulcer development. Dogs with liver disease, kidney disease, or other systemic conditions that predispose to ulceration should have these conditions well-managed. Regular monitoring allows early detection of disease progression that might increase ulcer risk. Mast cell tumors should be promptly treated given their propensity to cause severe gastric ulceration. Stress reduction for hospitalized or critically ill dogs, along with prophylactic gastroprotection, helps prevent stress ulcers.

Nutritional management supports gastric mucosal health and may help prevent ulceration. Feeding consistent, high-quality diets avoids gastric irritation from dietary indiscretion. Regular mealtimes help regulate gastric acid secretion. Avoiding known dietary triggers such as high-fat foods, spicy table scraps, or garbage helps maintain mucosal integrity. Ensuring adequate hydration supports all body systems including the gastrointestinal tract. For dogs prone to gastric issues, feeding multiple smaller meals rather than one large meal may reduce gastric distension and acid concentration.

Living with and managing a dog recovering from or at risk for gastric ulcers requires attention to daily routines, medication compliance, dietary management, and ongoing monitoring. While the acute phase of treatment is managed primarily by the veterinary team, long-term success depends on consistent home care and owner vigilance for signs of recurrence. With proper management, most dogs with a history of gastric ulcers can live normal, comfortable lives.

Medication management is often central to living with a dog affected by or at risk for gastric ulcers. During active treatment, acid suppressors and gastroprotectants must be given consistently as prescribed. Sucralfate timing is particularly important, requiring administration on an empty stomach for optimal effectiveness, typically one hour before meals and other medications. For dogs that previously developed ulcers from NSAIDs, alternative pain management protocols become part of daily life. Owners should maintain an adequate supply of medications and understand what each medication does to ensure treatment adherence.

Dietary management supports healing and helps prevent recurrence. During recovery, dogs typically do best with bland, easily digestible diets fed in small, frequent meals. Gradually transitioning back to regular food once healing is confirmed prevents gastric upset. Long-term, many dogs benefit from continued feeding of multiple smaller meals rather than one large daily meal. High-fat foods and dietary indiscretion should be avoided. Providing a calm, consistent eating environment reduces stress-related factors that can affect gastric health. Monitoring appetite and eating patterns helps detect early signs of recurrence.

Ongoing monitoring enables early detection of any problems. Owners should watch for signs of gastric discomfort including reduced appetite, nausea behaviors, vomiting, and changes in stool color or consistency. Any vomiting of blood or dark, tarry stools warrants immediate veterinary contact. Regular weigh-ins help detect gradual changes in body condition. Veterinary check-ups at recommended intervals allow professional assessment and adjustment of management strategies as needed. Dogs receiving long-term medications may need periodic blood work to monitor for side effects.

Quality of life for dogs with a history of gastric ulcers can be excellent with appropriate management. Most dogs return to normal activity levels once ulcers have healed. Exercise supports overall health and need not be restricted in recovered dogs unless other conditions require it. Mental stimulation and social interaction remain important. The main lifestyle considerations involve medication timing, dietary consistency, and avoiding known triggers. Owners should inform pet sitters, boarders, and anyone else who cares for the dog about the dog's history and management needs.

Caregiver considerations include understanding the condition, maintaining communication with the veterinary team, and managing the emotional aspects of caring for a dog with health issues. Keeping records of symptoms, medications, and veterinary visits helps track the dog's progress and provides useful information for veterinary appointments. Financial planning for ongoing medications and monitoring helps ensure consistent care. Support from the veterinary team and connection with other pet owners facing similar situations can be valuable for owners managing chronic or recurrent conditions.

Unlike many other canine conditions, gastric ulcers do not show strong breed-related predisposition based on genetics or conformation alone. Instead, the risk of gastric ulcers relates primarily to exposure to ulcer-causing factors such as medications and underlying diseases that may themselves have breed associations. Understanding these indirect relationships helps identify dogs that may benefit from closer monitoring and preventive strategies.

Breeds commonly requiring NSAID therapy may have increased ulcer exposure simply due to medication use. Large and giant breeds prone to osteoarthritis and other painful musculoskeletal conditions, including Labrador Retrievers, Golden Retrievers, German Shepherds, and Rottweilers, frequently receive NSAIDs for pain management. Breeds predisposed to orthopedic conditions requiring surgical intervention may receive perioperative NSAIDs. Athletic and working breeds may receive NSAIDs for sports-related injuries. The ulcer risk in these dogs relates to the medication exposure rather than inherent breed susceptibility to ulceration.

Breeds predisposed to conditions that cause secondary gastric ulceration may face elevated risk. Breeds with higher prevalence of mast cell tumors, including Boxers, Boston Terriers, and Labrador Retrievers, may develop tumor-associated gastric ulceration. Breeds prone to liver disease may have increased ulcer risk from hepatic dysfunction. West Highland White Terriers, Cocker Spaniels, and Doberman Pinschers have higher rates of certain liver conditions. Breeds predisposed to Addison's disease, including Standard Poodles, Portuguese Water Dogs, and Bearded Collies, may present with gastrointestinal ulceration during hypoadrenal crises.

For owners of at-risk dogs, awareness and communication with veterinarians are key to prevention. When NSAIDs are prescribed, discussing gastroprotective options helps reduce risk. Regular health screening may detect underlying conditions that predispose to ulceration before complications develop. Knowing the signs of gastric ulcers enables early recognition and treatment. For breeds with known predisposition to mast cell tumors, prompt evaluation of any skin masses helps prevent tumor-associated ulceration through early treatment.

Gastric ulcers in dogs frequently occur alongside other conditions, either as a consequence of primary diseases, as complications affecting the same body systems, or simply sharing common risk factors. Understanding these relationships helps veterinarians develop comprehensive diagnostic and treatment plans while enabling owners to recognize the broader context of their dog's health situation.

Several conditions commonly co-occur with or cause gastric ulcers. Liver disease and gastric ulcers are strongly associated, with hepatic dysfunction contributing to ulceration through multiple mechanisms and ulcer-related bleeding potentially worsening liver function through increased protein load. Kidney disease similarly predisposes to gastric ulceration while the stress of ulcer-related illness can worsen renal function. Mast cell tumors cause gastric ulceration through excessive histamine release and must be considered in any dog with unexplained severe ulceration. Inflammatory bowel disease may affect the stomach as well as intestines and can contribute to ulcer formation. Pancreatitis and gastric ulcers may occur together, particularly in critically ill dogs.

Other gastric conditions share features with or may be confused with gastric ulcers. Acute gastritis causes similar symptoms including vomiting and reduced appetite but involves inflammation without the localized deep erosions characteristic of ulcers. Chronic gastritis may predispose to ulcer development or occur alongside ulceration. Gastric erosions represent a milder form of mucosal damage that may precede ulcer formation. Gastric tumors can present with similar symptoms and may cause secondary ulceration; biopsies during endoscopy help differentiate these conditions. Gastric motility disorders can cause vomiting and discomfort and may occur secondary to ulcer-related changes.

Complications of gastric ulcers represent serious related conditions requiring urgent attention. Gastric perforation occurs when an ulcer erodes completely through the stomach wall, releasing gastric contents into the abdomen and causing peritonitis. This life-threatening complication requires emergency surgery. Gastric outlet obstruction can develop from scarring and inflammation around healed ulcers, particularly those near the pylorus. Severe anemia from chronic blood loss affects multiple body systems and may require blood transfusion. Aspiration pneumonia can occur if bloody gastric contents are inhaled during vomiting. Recognition of these potential complications guides monitoring during ulcer treatment and recovery.